1. Cell Biology

Fluidics system for resolving concentration-dependent effects of dissolved gases on tissue metabolism

  1. Varun Kamat
  2. Brian M Robbings
  3. Seung-Ryoung Jung
  4. John Kelly
  5. James B Hurley
  6. Kenneth P Bube
  7. Ian R Sweet  Is a corresponding author
  1. University of Washington, United States
  2. VICI Metronics, United States
https://doi.org/10.7554/eLife.66716
Share this article
Cite this article
  1. Varun Kamat
  2. Brian M Robbings
  3. Seung-Ryoung Jung
  4. John Kelly
  5. James B Hurley
  6. Kenneth P Bube
  7. Ian R Sweet
(2021)
Fluidics system for resolving concentration-dependent effects of dissolved gases on tissue metabolism
eLife 10:e66716.
https://doi.org/10.7554/eLife.66716
  2. Download BibTeX
  3. Download .RIS

Abstract

Oxygen (O2) and other dissolved gases such as the gasotransmitters H2S, CO and NO affect cell metabolism and function. To evaluate effects of dissolved gases on processes in tissue, we developed a fluidics system that controls dissolved gases while simultaneously measuring parameters of electron transport, metabolism and secretory function. We use pancreatic islets, retina and liver from rodents to highlight its ability to assess effects of O2 and H2S. Protocols aimed at emulating hypoxia-reperfusion conditions resolved a previously unrecognized transient spike in O2 consumption rate (OCR) following replenishment of O2, and tissue-specific recovery of OCR following hypoxia. The system revealed both inhibitory and stimulatory effects of H2S on insulin secretion rate from isolated islets. The unique ability of this new system to quantify metabolic state and cell function in response to precise changes in dissolved gases provides a powerful platform for cell physiologists to study a wide range of disease states.

Data availability

Data for all graphs are contained in Excel files named as the same name as the Figure followed by Source Data.

Article and author information

Author details

  1. Varun Kamat

    Department of Medicine, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.

  2. Brian M Robbings

    Department of Biochemistry, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.

  3. Seung-Ryoung Jung

    Department of Biochemistry, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.

  4. John Kelly

    Analytical Analysis, VICI Metronics, Poulsbo, United States
    Competing interests
    John Kelly, John Kelly through his employment at VICI Metronic, has a competing interest for the permeation tubes used in the study..

  5. James B Hurley

    Department of Biochemistry, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7754-0705

  6. Kenneth P Bube

    Department of Mathematics, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.

  7. Ian R Sweet

    Department of Medicine, University of Washington, Seattle, United States
    For correspondence
    isweet@uw.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7565-1663

Funding

National Science Foundation (1853066)

  • Brian M Robbings
  • James B Hurley

National Institute of Diabetes and Digestive and Kidney Diseases (DK17047)

  • Ian R Sweet

National Eye Institute (EY006641)

  • James B Hurley
  • Ian R Sweet

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#4091-01) of the University of Washington. All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.

Copyright

© 2021, Kamat et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 583
    views
  • 88
    downloads
  • 8
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Varun Kamat
  2. Brian M Robbings
  3. Seung-Ryoung Jung
  4. John Kelly
  5. James B Hurley
  6. Kenneth P Bube
  7. Ian R Sweet
(2021)
Fluidics system for resolving concentration-dependent effects of dissolved gases on tissue metabolism
eLife 10:e66716.
https://doi.org/10.7554/eLife.66716

Share this article

https://doi.org/10.7554/eLife.66716

Categories and tags

Research organisms

Further reading

    1. Cancer Biology
    2. Cell Biology

    N6-methyladenosine in DNA promotes genome stability

    Brooke A Conti, Leo Novikov ... Mariano Oppikofer
    Research Article

    DNA base lesions, such as incorporation of uracil into DNA or base mismatches, can be mutagenic and toxic to replicating cells. To discover factors in repair of genomic uracil, we performed a CRISPR knockout screen in the presence of floxuridine, a chemotherapeutic agent that incorporates uracil and fluorouracil into DNA. We identified known factors, such as uracil DNA N-glycosylase (UNG), and unknown factors, such as the N6-adenosine methyltransferase, METTL3, as required to overcome floxuridine-driven cytotoxicity. Visualized with immunofluorescence, the product of METTL3 activity, N6-methyladenosine, formed nuclear foci in cells treated with floxuridine. The observed N6-methyladenosine was embedded in DNA, called 6mA, and these results were confirmed using an orthogonal approach, liquid chromatography coupled to tandem mass spectrometry. METTL3 and 6mA were required for repair of lesions driven by additional base-damaging agents, including raltitrexed, gemcitabine, and hydroxyurea. Our results establish a role for METTL3 and 6mA in promoting genome stability in mammalian cells, especially in response to base damage.

    1. Cell Biology

    Small-molecule activation of TFEB alleviates Niemann–Pick disease type C via promoting lysosomal exocytosis and biogenesis

    Kaili Du, Hongyu Chen ... Dan Li
    Research Article

    Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.